LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 35.77 | 21.74 | 1762 | 2602 | 0.6770 | 0.8901 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 35.77 | 21.74 | 32 | 2602 | 0.0123 | 0.0576 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 35.77 | 21.74 | 1750 | 2602 | 0.6723 | 0.8882 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 37.74 | 21.74 | 1831 | 2828 | 0.6474 | 0.8799 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 37.74 | 21.74 | 1857 | 2828 | 0.6566 | 0.8837 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 37.74 | 21.74 | 42 | 2828 | 0.0148 | 0.0983 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 37.74 | 21.74 | 1863 | 2828 | 0.6587 | 0.8846 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 39.71 | 21.74 | 1960 | 3084 | 0.6355 | 0.8771 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 39.71 | 21.74 | 1986 | 3084 | 0.6439 | 0.8806 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 39.71 | 21.74 | 57 | 3084 | 0.0185 | 0.1444 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 39.71 | 21.74 | 1929 | 3084 | 0.6255 | 0.8729 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 41.68 | 21.74 | 2018 | 3418 | 0.5903 | 0.8606 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 41.68 | 21.74 | 2042 | 3418 | 0.5973 | 0.8636 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 41.68 | 21.74 | 67 | 3418 | 0.0196 | 0.1668 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 41.68 | 21.74 | 2036 | 3418 | 0.5955 | 0.8629 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 43.65 | 21.74 | 2122 | 3754 | 0.5652 | 0.8522 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 43.65 | 21.74 | 2146 | 3754 | 0.5716 | 0.8550 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 43.65 | 21.74 | 84 | 3754 | 0.0224 | 0.1995 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 43.65 | 21.74 | 2154 | 3754 | 0.5738 | 0.8560 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 45.62 | 21.74 | 2223 | 4150 | 0.5356 | 0.8418 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 45.62 | 21.74 | 2241 | 4150 | 0.5399 | 0.8437 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 45.62 | 21.74 | 96 | 4150 | 0.0231 | 0.2166 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 45.62 | 21.74 | 2286 | 4150 | 0.5507 | 0.8486 | MN20160310_N01 | N13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 47.59 | 21.74 | 2417 | 4492 | 0.5381 | 0.8452 | MN20160310_N01 | I11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 47.59 | 21.74 | 2449 | 4492 | 0.5452 | 0.8483 | MN20160310_N01 | I11 |